Pdt Partners, LLC Cara Therapeutics, Inc. Transaction History

Pdt Partners, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$2.83 - $4.94 $47,889 - $83,594	-16,922 Reduced 16.59%	85,088 $240,000
Q1 2023 May 15, 2023	BUY	$4.89 - $12.27 $316,275 - $793,599	64,678 Added 173.25%	102,010 $500,000
Q4 2022 Feb 14, 2023	BUY	$8.88 - $12.77 $107,226 - $154,197	12,075 Added 47.81%	37,332 $400,000
Q3 2022 Nov 14, 2022	SELL	$8.24 - $12.56 $126,599 - $192,971	-15,364 Reduced 37.82%	25,257 $236,000
Q2 2022 Aug 15, 2022	SELL	$7.45 - $13.84 $543,075 - $1.01 Million	-72,896 Reduced 64.22%	40,621 $371,000

Q1 2022 May 16, 2022	BUY	$9.94 - $12.65 $38,766 - $49,335	3,900 Added 3.56%	113,517 $1.38 Million
Q4 2021 Feb 14, 2022	BUY	$11.99 - $18.14 $59,578 - $90,137	4,969 Added 4.75%	109,617 $1.34 Million
Q3 2021 Nov 15, 2021	BUY	$11.55 - $16.06 $353,614 - $491,692	30,616 Added 41.36%	104,648 $1.62 Million
Q2 2021 Aug 16, 2021	BUY	$12.38 - $29.19 $110,986 - $261,688	8,965 Added 13.78%	74,032 $1.06 Million
Q1 2021 May 17, 2021	SELL	$15.07 - $21.71 $116,084 - $167,232	-7,703 Reduced 10.59%	65,067 $1.41 Million
Q4 2020 Feb 16, 2021	SELL	$12.72 - $16.16 $50,040 - $63,573	-3,934 Reduced 5.13%	72,770 $1.1 Million
Q3 2020 Nov 16, 2020	BUY	$12.34 - $17.92 $109,875 - $159,559	8,904 Added 13.13%	76,704 $976,000
Q2 2020 Aug 14, 2020	BUY	$12.39 - $17.33 $840,042 - $1.17 Million	67,800 New	67,800 $1.16 Million

102

21.5M

50K

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $14M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.